Skip to Content
Merck
  • Second messengers mediating the proliferation and collagen synthesis of tenocytes induced by low-level laser irradiation.

Second messengers mediating the proliferation and collagen synthesis of tenocytes induced by low-level laser irradiation.

Lasers in medical science (2014-09-19)
Mei-Hsiu Chen, Yun-Chien Huang, Jui-Sheng Sun, Yuan-Hung Chao, Ming-Hong Chen
ABSTRACT

For decades, low-level laser therapy (LLLT) has widespread applications in tendon-related injuries. Although the therapeutic effect of LLLT could be explained by photostimulation of target tissue and cells, how tenocytes sense photonic energy and convert them into cascades of cellular and molecular events is still not well understood. This study was designed to elucidate the effects of LLLT on cell proliferation and collagen synthesis by examining the associated second messengers including ATP, Ca(2+), and nitric oxide using rat Achilles tenocytes. Moreover, proliferating cell nuclear antigen (PCNA) and transforming growth factor-β1 (TGF-β1) related to cell proliferation and matrix metabolism were also studied. The results showed that 904 nm GaAs laser of 1 J/cm(2) could significantly increase the MTT activity and collagen synthesis of tenocytes. Second messengers including ATP and intracellular Ca2+ were increased after laser treatment. Quantitative PCR analysis of tenocytes treated with laser revealed up-regulated expression of PCNA, type I collagen, and TGF-β1. Besides, laser-induced TGF-β1 expression was significantly inhibited by extracellular signal-regulated kinase (ERK) specific inhibitor (PD98059). The findings suggested that LLLT stimulated ATP production and increased intracellular calcium concentration. Directly or indirectly via production of TGF-β1, these second messengers mediated the proliferation of tenocytes and synthesis of collagen.

MATERIALS
Product Number
Brand
Product Description

Supelco
Sulfanilamide melting point standard, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Sulfanilamide, VETRANAL®, analytical standard
Sigma-Aldrich
Sulfanilamide, puriss. p.a., ≥98% (calc. to the dried substance)
Sigma-Aldrich
Sulfanilamide, ≥98%
USP
Sulfanilamide, United States Pharmacopeia (USP) Reference Standard
USP
Sulfanilamide Melting Point Standard, United States Pharmacopeia (USP) Reference Standard
Sulfanilamide, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Ethylenediamine solution, technical, 75-80%
Supelco
Ethylenediamine, analytical standard
Sigma-Aldrich
Ethylenediamine, meets USP testing specifications
Sigma-Aldrich
Ethylenediamine, puriss. p.a., absolute, ≥99.5% (GC)
Sigma-Aldrich
Ethylenediamine, ReagentPlus®, ≥99%
Sigma-Aldrich
Ethylenediamine, BioXtra
Sigma-Aldrich
Ethylenediamine, purified by redistillation, ≥99.5%